drugset / Trial / NCT02396030
Different Schemes of Magnesium Sulfate for Preeclampsia
RandomizedParallel-groupTriple-blindPrevention
Summary
Eclampsia is an obstetric emergency capable of prophylaxis. To prevent and control seizures, there is no doubt that the magnesium sulfate (MgSO4) is the ideal drug. However, there are still questions regarding its use and dose. The scheme and the optimal time of administration remain to be elucidated. The objective of this trial is to compare the effectiveness and safety of intravenous magnesium sulfate in the maintenance phase 1g / h versus 2 g / h to prevent eclampsia in pregnant and postpartum women with severe preeclampsia (pure or superimposed).
Timeline
- Start
- 2015-03
- Primary completion
- 2016-03
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Magnesium Sulfate | Other / unclassified | 1 g | Intravenous |
| Comparator | Magnesium Sulfate | Other / unclassified | 2 g | Intravenous |